BP8 to acquire China-based Foshan Gedishi Biotechnology Co
Filed with ASX · · 3 pages · English
Earlier from BPH Global
- Joint venture with Singapore-based Chemokine Yuesheng
- 30 Days Market Update on China business activities
- Market Update on China business activities
- Appointment of Consultant to manage Singapore R&D Facility
- Market Update
Later from BPH Global
- BPH Global receives funding commitments of A$800,000
- 60 Days' Market Update on China-based business activities
- Results of Meeting and Board Changes
- Sale of platform in East Johor Strait
- Renewal of China Tobacco Agreements
Follow BPH Global into a list and get an email when it puts out news.
Follow BPH Global